Transactions
October 8 2015
GoodRx Received A Growth Investment From Francisco Partners & Spectrum Equity
Company Description
GoodRx provides drug price transparency, cost containment, and consumer engagement solutions through simple web and mobile interfaces. The Company delivers significant savings to consumers by directing individuals to the lowest cost alternative, saving consumers up to 80% on their medications. The effectiveness and ease of use of the GoodRx solution is also validated by its ranking as the #1 mobile medical app. GoodRx’s transparency and engagement solutions fill the consumer decision-making void in healthcare and enhance outcomes through improved medication adherence and consumer education. GoodRx also offers a “funded” solution, whereby GoodRx partners with pharmacy benefit managers to provide employee engagement solutions for employer drug benefit plans.
Objectives
TripleTree was engaged by GoodRx to evaluate its strategic alternatives and to find a partner that would support the unique value proposition and tremendous growth trajectory of the business. The Company was looking for a partner that would help fuel further growth and elevate the business into an industry leader with scale, brand recognition, and multiple expansion opportunities.
Results
GoodRx realized a successful growth investment from Francisco Partners and Spectrum Equity, who were attracted to GoodRx’s tremendous growth trajectory, entrenched and unrivaled market position, powerful consumer and employer value proposition, immense addressable market, and unparalleled founder experience. Francisco Partners and Spectrum Equity distinguished themselves due to their shared vision for the future of the business, as well as their ability to support management through their complementary expertise across consumerism, healthcare, and technology.
LEAD INVESTMENT BANKERS
David Brownlie
Jonathan Hill
Nate Chivers
Scott Donahue
Company Description
GoodRx provides drug price transparency, cost containment, and consumer engagement solutions through simple web and mobile interfaces. The Company delivers significant savings to consumers by directing individuals to the lowest cost alternative, saving consumers up to 80% on their medications. The effectiveness and ease of use of the GoodRx solution is also validated by its ranking as the #1 mobile medical app. GoodRx’s transparency and engagement solutions fill the consumer decision-making void in healthcare and enhance outcomes through improved medication adherence and consumer education. GoodRx also offers a “funded” solution, whereby GoodRx partners with pharmacy benefit managers to provide employee engagement solutions for employer drug benefit plans.
Objectives
TripleTree was engaged by GoodRx to evaluate its strategic alternatives and to find a partner that would support the unique value proposition and tremendous growth trajectory of the business. The Company was looking for a partner that would help fuel further growth and elevate the business into an industry leader with scale, brand recognition, and multiple expansion opportunities.
Results
GoodRx realized a successful growth investment from Francisco Partners and Spectrum Equity, who were attracted to GoodRx’s tremendous growth trajectory, entrenched and unrivaled market position, powerful consumer and employer value proposition, immense addressable market, and unparalleled founder experience. Francisco Partners and Spectrum Equity distinguished themselves due to their shared vision for the future of the business, as well as their ability to support management through their complementary expertise across consumerism, healthcare, and technology.
LEAD INVESTMENT BANKERS
David Brownlie
Jonathan Hill
Nate Chivers
Scott Donahue
We prioritize your privacy. We do not sell your information and will only send occasional, relevant emails.
Copyright © 2024 TripleTree, LLC.
All Rights Reserved